Therapeutic Drug Monitoring Market Intelligence Report - Global Forecast to 2027

The Global Therapeutic Drug Monitoring Market is projected to reach USD 6,837.21 million by 2027 from USD 2,850.24 million in 2021, at a CAGR 15.69% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Therapeutic Drug Monitoring Market size was estimated at USD 989.60 million in 2021 and expected to reach USD 1,127.03 million in 2022, at a CAGR 15.25% to reach USD 2,319.31 million by 2027.
• The Asia-Pacific Therapeutic Drug Monitoring Market size was estimated at USD 733.48 million in 2021 and expected to reach USD 860.71 million in 2022, at a CAGR 16.38% to reach USD 1,823.05 million by 2027.
• The Europe, Middle East & Africa Therapeutic Drug Monitoring Market size was estimated at USD 1,127.15 million in 2021 and expected to reach USD 1,296.65 million in 2022, at a CAGR 15.63% to reach USD 2,694.84 million by 2027.

Market Segmentation & Coverage:

The report on therapeutic drug monitoring identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the therapeutic drug monitoring to forecast the revenues and analyze the trends in each of the following sub-markets:

Product:

• Consumables
• Data Management Services
• Equipment
  • Chromatography & MS Detectors
  • Clinical Chemistry Analyzers
  • Immunoassay Analyzers

Technology:

• Chromatography-MS
  • GC-MS
  • LC-MS
• Immunoassays
  • Chemiluminescence Immunoassays
  • Colorimetric Immunoassays
  • Fluorescence Immunoassays
  • Radioimmunoassays
• Proteomic Technologies

Drug Class:

• Antiarrhythmic Drugs
• Antibiotic Drugs
• Antiepileptic Drugs
• Bronchodilator Drugs
• Immunosuppressant Drugs
• Psychoactive Drugs

End-User:

• Hospital Labs
• Private Labs

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • Arkansas
    • California
    • Florida
    • Illinois
    • Kentucky
    • Minnesota
    • New Jersey
    • New Mexico
    • New York
    • Ohio
    • Pennsylvania
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Abbott Laboratories
• Agilent Technologies, Inc.
• apDia Group
• ARK Diagnostics, Inc.
• Bio-Rad Laboratories, Inc.
• bioMérieux SA
• Bühlmann Laboratories AG
• Cambridge Life Sciences Limited
• Chromsystems Instruments & Chemicals GmbH
• Danaher Corporation
• DiaSystem Scandinavia AB
• Eagle Biosciences, Inc.
• Exagen Inc.
• F. Hoffmann-La Roche AG
• Fujirebio Europe N.V.
• Grifols, S.A.
• Merck KGaA
• Myriad Genetics, Inc.
• R-Biopharm AG
• Randox Laboratories, Ltd.
• Sekisui Chemical Co Ltd.
• Siemens Healthineers AG
• Tecan Trading AG
• Theradiag
• Thermo Fisher Scientific, Inc.